CeriBell Reports Q1 2026 Earnings with Revenue Growth
CeriBell (CBLL) reported first-quarter earnings for 2026, showing total revenue of $26.5 million, a 29% year-over-year increase driven by record headband utilization and new hospital account additions. The company also launched its neonate and pediatric seizure monitoring products commercially after successful pilot results.
Tickers: $CBLL
Topics: FDA_clearance growth product_launches revenue